ClinicalTrials.gov
public full text
Public Domain
Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).
This study aims to assess the efficacy of Epidiolex in patients with ESES. ESES is characterized by sleep potentiated spikes with a spike index greater than 85% (conventional definition) and 50% (new definition)1. Several drugs including: steroids, intravenous Gama globulin, Clobazam, other benzodiazepines, Valproic acid, and other anti-epileptic drugs have been tried with mixed benefits2,3. Cannabidiol (CBD) would provide a novel mechanism of action to assess for its efficacy in this population. This will be a double-blind placebo-controlled crossover clinical trial.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Trends in the studies of pharmacoresistant epilepsy- a review based on literature analysis (2015-2025)#5558
- Gabapentin for Sleep in Critically Ill Patients#1137388
- The Efficacy and Safety of At-home Transcutaneous Electrical Nerve Stimulation in Insomnia#1059644
- Treatment of Refractory Status Epilepticus#1140267
- Cannabidiol in Children With Refractory Epileptic Encephalopathy#865900
Record · ID 879168
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive